Nadia Valin
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
Papers in
- Virology 17
- HIV Research and Treatment 17
-
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 15
- Tuberculosis Research and Epidemiology 6
- Co-authors
- Pierre‐Marie GirardKarine LacombeArnaud FontanetLaurent MarsollierRégis PouillotSara EyangohFrançoise PortaelsL. Fonquernie
- Journals
- Clinical Infectious Diseases (5 papers)AIDS (5 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)BMC Infectious Diseases (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- FranceVietnamUnited States
In The Last Decade
Nadia Valin
50 papers receiving 777 citations
Peers
Comparison fields: 5 of 91
- Virology 168
- Infectious Diseases 410
- Applied Microbiology and Biotechnology 31
- Emergency Medicine 128
- Epidemiology 409
Countries citing papers authored by Nadia Valin
This map shows the geographic impact of Nadia Valin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Valin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Valin more than expected).
Fields of papers citing papers by Nadia Valin
This network shows the impact of papers produced by Nadia Valin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Valin. The network helps show where Nadia Valin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nadia Valin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 0 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 7 | |
| 12 | 2019 | 8 | |
| 13 | 2019 | 0 | |
| 14 | 2018 | 20 | |
| 15 | 2017 | 41 | |
| 16 | 2013 | 17 | |
| 17 | 2013 | 49 | |
| 18 | 2012 | 40 | |
| 19 | 2008 | 1 | |
| 20 | 2006 | 4 |
About Nadia Valin
Nadia Valin is a scholar working on Virology, Infectious Diseases, Hepatology, Epidemiology and Microbiology, having authored 55 papers that have together received 791 indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (15 papers), Hepatitis C virus research (8 papers), Tuberculosis Research and Epidemiology (6 papers), HIV, Drug Use, Sexual Risk (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and HIV-related health complications and treatments (5 papers). The work is most often cited by research in Virology (168 citations), Infectious Diseases (410 citations), Applied Microbiology and Biotechnology (31 citations), Emergency Medicine (128 citations) and Epidemiology (409 citations). Nadia Valin has collaborated with scholars based in France, Vietnam and United States. Frequent co-authors include Pierre‐Marie Girard, Karine Lacombe, Arnaud Fontanet, Laurent Marsollier, Régis Pouillot, Sara Eyangoh, Françoise Portaels, L. Fonquernie, V. Lalande and Jérôme Pacanowski. Their work appears in journals such as Clinical Infectious Diseases, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, BMC Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.